Thomas Patrick Kelly, CFO of Xenon Pharmaceuticals XENE, has filed 1 purchase and 7 sales on the open market. Over the past 12 months that comes to a net purchase of $559.7K. The latest trade was on 09/30.

TK

TK

Thomas Patrick Kelly

CFO

Company

Xenon Pharmaceuticals XENE

First filing

23/01/19

Trades

26 trades

Buys / sales

1 / 7

12-month net buying

$559.7K

Last trade

09/30

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Xenon PharmaceuticalsXENE	Open-market buy	09/30	10/01	15,000 sh	$37.32	$559,740	No record
DP Deciphera Pharmaceuticals	Open-market sale	24/02/16	24/02/20	3,010 sh	$15.62	$47,016.2	−3.6%
DP Deciphera Pharmaceuticals	Open-market sale	24/01/16	24/01/18	2,435 sh	$14.47	$35,234.45	−3.6%
DP Deciphera Pharmaceuticals	Open-market sale	23/12/13	23/12/14	2,792 sh	$15.37	$42,913.04	−3.9%
DP Deciphera Pharmaceuticals	Open-market sale	23/10/30	23/10/31	2,316 sh	$12.02	$27,838.32	−3.5%
DP Deciphera Pharmaceuticals	Open-market sale	23/06/16	23/06/21	1,655 sh	$14.40	$23,832	−2.8%
DP Deciphera Pharmaceuticals	Open-market sale	23/02/16	23/02/17	1,370 sh	$15.10	$20,687	−2.3%
DP Deciphera Pharmaceuticals	Open-market sale	23/01/17	23/01/19	2,403 sh	$21.24	$51,039.72	−5.2%